Previous 10 | Next 10 |
Data demonstrates potential of RaDaR to predict clinical response in stage III urothelial cancer FT. MYERS, FL / ACCESSWIRE / April 11, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, to...
NeoGenomics continues to add to its state-of-the-art multiomics solutions in world-class biopharma clinical trial and research services for global pharma companies FORT MYERS, FL / ACCESSWIRE / April 11, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and g...
FT. MYERS, FL / ACCESSWIRE / April 8, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans to release its first quarter 2022, financial results on Wednesday, April 27, 2022. The Compa...
Neogenomics performed excellently for shareholders between 2018 - early 2021, but since then things have begun to unravel at the company. The departure of long-time CEO Van Oort and appointment of Mark Mallon was a failure - Mallon's departure was announced last week, as Q1 and FY22 g...
NeoGenomics (NASDAQ:NEO) jumped 22% on speculation that the operator of cancer testing labs could become an activist target. NeoGenomics (NEO) shares have dropped "significantly" in recent months and the company had an "abrupt" management change and some "value-destructive" acquisitions,...
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO) on behalf of NeoGenomics stockholders. Our investigation concerns ...
The law firm of Kirby McInerney LLP is investigating potential claims against NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO ). The investigation concerns whether NeoGenomics has violated the federal securities laws and/or engaged in ...
Gainers: IGM Biosciences (IGMS) +105%. China SXT Pharmaceuticals (SXTC) +73%. Clever Leaves Holdings (CLVR) +42%. MicroVision (MVIS) +31%. LianBio (LIAN) +26%. TC Biopharm (TCBP) +26%. Robinhood Markets (HOOD) +25%. Kinnate Biopharma (KNTE) +24%. Auddia (AUUD) +23%. Molecular Templates (...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Twilio (NYSE: TWLO ) stock is on the move Tuesday as the U.S. Securities and Exchange Commission (SEC) weighs in on an insider trading scandal. Source: Piotr Swat / Shutterstock.com Let’s dive into everyt...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cancer-testing company NeoGenomics (NASDAQ: NEO ) is in the midst of a brutal pullback today after announcing it will miss guidance. NEO stock is down more than 30% so far on Tuesday. Source: Shutterstock So wha...
News, Short Squeeze, Breakout and More Instantly...
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that it will report its second quarter 2024 financial results after the close of the U.S. financial markets on Monday, July 29, 2024. Company management will host a webcast and conference call at 4:30 ...
2024-06-23 10:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that Fort Myers’ Mayor, Kevin Anderson, will be dedicating June as NeoGenomics’ Commitment to Cancer Month to honor cancer survivors and those currently living with cancer. Headquartered in...